CBS News
US · 3 hrs ago
✦ 78✓ Factual
New drug nearly doubles survival rates in some pancreatic cancer patients, study says
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 15/100
ObjectivePartisan
Low partisan intensity — consistent with factual reporting✓ Fair headline
A new drug called daraxonrasib has demonstrated the ability to significantly extend survival in some patients with advanced pancreatic cancer, according to recent research findings.
New drug nearly doubles survival rates in some pancreatic cancer patients, study says
New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!